Evaluation of the biocompatibility of a chitosan scaffold in mice

被引:556
作者
VandeVord, PJ
Matthew, HWT
DeSilva, SP
Mayton, L
Wu, B
Wooley, PH [1 ]
机构
[1] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA
[2] Wayne State Univ, Hutzel Hosp 1S, Dept Orthopaed Surg, Detroit, MI 48201 USA
[3] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 59卷 / 03期
关键词
chitosan; biocompatibility; mice; implantation; immune response; tissue engineering;
D O I
10.1002/jbm.1270
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chitosan scaffolds appear to be suitable for a variety of tissue engineering applications. This study addressed the biocompatibility of chitosan in a mouse implantation model. Porous chitosan scaffolds were implanted in mice, and animals were sacrificed after 1, 2, 4, 8, or 12 weeks. Macroscopic inspection of the implantation site revealed no pathological inflammatory responses. Histological assessment indicated marked neutrophil accumulation within the implant, which resolved with increasing implantation time. Gram staining and limulus assays revealed no evidence of infection or endotoxin. Collagen was observed within the chitosan pore spaces, indicating that connective tissue matrix was deposited within the implant. Angiogenic activity associated with the external implant surface was also observed. Cellular immune responses were determined by lymphocyte proliferation assays, and antibody responses were measured using ELISA techniques. These assays indicated a very low incidence of chitosan-specific reactions. Although there was a large migration of neutrophils into the implantation area, there were minimal signs of any inflammatory reaction to the material itself. This preliminary study demonstrates that chitosan has a high degree of biocompatibility in this animal model. Overall, the findings suggest that chitosan may be suitable for the development of implantable materials. (C) 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 585-590, 2002.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 26 条
[1]   Chitosan microcapsules as controlled release systems for insulin [J].
Aiedeh, K ;
Gianasi, E ;
Orienti, I ;
Zecchi, V .
JOURNAL OF MICROENCAPSULATION, 1997, 14 (05) :567-576
[2]   Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules [J].
DeVos, P ;
DeHaan, B ;
VanSchilfgaarde, R .
BIOMATERIALS, 1997, 18 (03) :273-278
[3]   OBSTACLES IN THE APPLICATION OF MICROENCAPSULATION IN ISLET TRANSPLANTATION [J].
DEVOS, P ;
WOLTERS, GHJ ;
FRITSCHY, WM ;
VANSCHILFGAARDE, R .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (04) :205-212
[4]   N-ACETYLATION IN CHITOSAN AND THE RATE OF ITS ENZYMIC-HYDROLYSIS [J].
HIRANO, S ;
TSUCHIDA, H ;
NAGAO, N .
BIOMATERIALS, 1989, 10 (08) :574-576
[5]   Effect of chitosan implantation on activation of canine macrophages and polymorphonuclear cells after surgical stress [J].
Kosaka, T ;
Kaneko, Y ;
Nakada, Y ;
Matsuura, M ;
Tanaka, S .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 1996, 58 (10) :963-967
[6]  
Lahiji A, 2000, J BIOMED MATER RES, V51, P586
[7]   BLOOD COMPATIBILITY AND BIODEGRADABILITY OF PARTIALLY N-ACYLATED CHITOSAN DERIVATIVES [J].
LEE, KY ;
HA, WS ;
PARK, WH .
BIOMATERIALS, 1995, 16 (16) :1211-1216
[8]   The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier [J].
Lee, YM ;
Park, YJ ;
Lee, SJ ;
Ku, Y ;
Han, SB ;
Klokkevold, PR ;
Chung, CP .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (03) :418-424
[9]   Porous chitosan scaffolds for tissue engineering [J].
Madihally, SV ;
Matthew, HWT .
BIOMATERIALS, 1999, 20 (12) :1133-1142
[10]   The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS.2. Microencapsulated CSF-I and LM-10 cells as delivery systems [J].
Maysinger, D ;
Berezovskaya, O ;
Fedoroff, S .
EXPERIMENTAL NEUROLOGY, 1996, 141 (01) :47-56